论文部分内容阅读
目的:观察疏血通注射液辅助治疗2型糖尿病(T2DM)合并血脂异常的临床疗效。方法:将68例T2DM合并血脂异常患者随机分为治疗组34例和对照组34例,对照组采用他汀类或贝特类药物治疗,治疗组在对照组治疗基础上加用疏血通注射液治疗。结果:治疗前,治疗组和对照组的甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)和总胆固醇(TC)水平间比较,均无显著性差异(均P>0.05)。治疗后,2组的TG和LDL-C水平均较治疗前显著下降(P<0.05),但治疗组的TG和LDL-C水平均显著低于对照组(P<0.05)。结论:疏血通注射液能辅助降低T2DM合并血脂异常患者的TG和LDL-C水平。
Objective: To observe the clinical effect of Shuxuetong injection in the treatment of type 2 diabetes mellitus (T2DM) with dyslipidemia. Methods: Sixty-eight patients with T2DM and dyslipidemia were randomly divided into treatment group (34 cases) and control group (34 cases). The control group was treated with statins or fibrates. The treatment group was treated with Shuxuetong injection treatment. Results: The levels of triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in the treatment group and the control group before treatment were No significant difference (all P> 0.05). After treatment, the levels of TG and LDL-C in both groups were significantly lower than those before treatment (P <0.05), but TG and LDL-C in the treatment group were significantly lower than those in the control group (P <0.05). Conclusion: Shuxuetong injection can help reduce the level of TG and LDL-C in T2DM patients with dyslipidemia.